DBV Technologies | Gewinn Je Aktie





Eps Veränderung Datum
Acadia Pharmaceuticals USD 0.42 0.26 2025-09
Alnylam Pharmaceuticals USD 2.9 2.58 2025-09
Amarin USD 0.08 0.11 2025-09
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
BioMarin Pharmaceutical USD 0.12 1.32 2025-09
DBV Technologies USD -0.24 1.31 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Galectin Therapeutics USD -0.2 0.01 2024-06
Halozyme Therapeutics USD 1.72 0.18 2025-09
Incyte USD 1.8 0.46 2025-12
Insmed USD -1.75 0.05 2025-09
Ionis Pharmaceuticals USD -0.8 1.5 2025-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
PTC Therapeutics USD 0.2 1.03 2025-09
Sarepta Therapeutics USD -0.13 2.15 2025-09
Ultragenyx Pharmaceutical USD -1.81 0.64 2025-09
United Therapeutics USD 7.16 0.75 2025-09


DBV Technologies Gewinn Je Aktie - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.